再鼎医药将于8月7日举行董事会会议以审批中期业绩

格隆汇
25 Jul

格隆汇7月25日丨再鼎医药(09688.HK)公告,董事会审核委员会将于2025年8月7日(星期四)审议及批准(其中包括)根据美国公认会计准则及美国证券交易委员会的适用规则编制的公司及其附属公司截至2025年6月30日止3个月及6个月的未经审核中期业绩及其发布。倘业绩获审核委员会批准,公司将于2025年8月7日(星期四)在香港联合交易所有限公司网站www.hkexnews.hk及公司网站www....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10